Postdialysis outcomes associated with consistent anemia treatment in predialysis patients with chronic kidney disease

Jay B. Wish, George M. Nassar, K. Schulman, M. del Aguila, R. Provenzano

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Aims: Anemia and cardiovascular (CV) events are major complications of chronic kidney disease (CKD) during dialysis. We conducted a retrospective observational study in CKD patients with anemia to evaluate the association between predialysis use of erythropoiesis-stimulating agents (ESAs) and postdialysis CV outcomes. Methods: The study analyzed claims data on incident hemodialysis patients aged ≥ 18 years (identified between January 2000 and November 2005). Patients were identified as anemic and ESA-treated prior to dialysis. ESA treatment was categorized into 4 consistency groups (from least to most consistent ESA use). Results: Of 5,848 hemodialysis patients, 52% were identified as anemic prior to onset of dialysis. Predialysis ESA treatment was received by 62% of anemic patients, with only 23% receiving the most consistent treatment. The risk of a CV event was significantly lower for the ESA-treated compared with ESA-untreated patients (relative risk (RR) 0.70, 95% (95% confidence intervals (CI) 0.61-0.82)). Compared with ESA-untreated, those who received ESAs had significantly lower risk of acute myocardial infarction (RR 0.65 (95% CI 0.44-0.95)) or inpatient mortality (RR 0.52 (95% CI 0.40-0.68)). ESA-treated patients in each of the 4 consistency groups had significantly lower risk of CV events compared with ESA-untreated patients, with the greatest benefit seen in patients who received most consistent ESA (RR 0.61 (95% Cl 0.48-0.76)). Conclusions: This analysis suggests consistent ESA use to treat anemia of CKD in the predialysis period is associated with improved cardiovascular outcomes in postdialysis patients.

Original languageEnglish (US)
Pages (from-to)251-259
Number of pages9
JournalClinical Nephrology
Volume69
Issue number4
DOIs
StatePublished - Jan 1 2008

Keywords

  • Anemia
  • CKD
  • ESA
  • Hemodialysis
  • Postdialysis outcomes

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Postdialysis outcomes associated with consistent anemia treatment in predialysis patients with chronic kidney disease'. Together they form a unique fingerprint.

Cite this